Graded Exercise Hypoxia Testing

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoints: details revised at 1 of 1 entry Show 6 more changesShow less
    • Trial completed
    • Final enrollment: 30 participants (planned 50)
    • Primary completion date changed from estimate of Apr 24, 2027 to Jul 30, 2025
    • Study completion date changed from estimate of Apr 24, 2028 to Sep 11, 2025
    • Eligibility criteria expanded, about 8 words
    • Site details revised at 1 of 2 sites
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 2 of 2 sites
    v3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Start date changed from estimate of Apr 24, 2025 to Apr 15, 2025
    v2
  4. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
1,024 trials monitored
See 128 trials at risk
The purpose of this study is to develop a single, standardized test to determine how individuals tolerate acute hypoxia in a stepwise fashion. We aim to evaluate the association between multiple factors, such as ventilatory compensation, heart rate response, acid-base changes, sex, pulmonary function, etc, which may explain why some individuals tolerate exercise in hypoxia better than others. Identifying these factors of association will inform future pharmacological and non-pharmacological attempts to combat acute hypoxic exercise.
Trial Details
NCT Number NCT06901284
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)
Hypoxia
Related terms Hypoxia
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov